Table 2 Clinical outcomes, awake surgery versus non-awake surgery for insular glioma.
From: Potential predictors of awake surgery failure for insular glioma
Outcome | Surgical resection, N = 24 | AS group, N = 13 | NAS group, N = 11 | p |
|---|---|---|---|---|
Residual tumor volume (cm3) | 0.015 | |||
Median | 12.9 | 2.2 | 41.4 | |
Range | 0–95.3 | 0–95.3 | 2.1–72.3 | |
EOR (%) | 0.004 | |||
Median | 78.5 | 87.7 | 58.0 | |
Range | 13.1–100 | 39.1–100 | 13.1–90.1 | |
Additional resection after iMRI | 10 (41.7%) | 6 (46.2%) | 4 (36.4%) | 0.70 |
Ischemic complication | 3 (12.5%) | 2 (15.4%) | 1 (9.1%) | 1.0 |
Hemorrhagic complication | 0 (0%) | 0 (0%) | 0 (0%) | 1.0 |
Deterioration of KPS at discharge | 0 (0%) | 0 (0%) | 0 (0%) | 1.0 |
Postoperative transient neurological deficits | 4 (16.7%) | 2 (15.4%) | 2 (18.2%) | 1.0 |
Postoperative permanent neurological deficits | 0% | 0% | 0% | 1.0 |
